Search

Displaying results 7731 - 7740 of 10000 in total
  1. Drug

    Solanezumab

    go.drugbank.com/drugs/DB11756
    Investigational

    Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.

  2. Drug

    norUrsodeoxycholic acid

    go.drugbank.com/drugs/DB16260
    Investigational

    norUrsodeoxycholic acid is under investigation in clinical trial NCT03872921 (Norursodeoxycholic Acid vs Placebo in PSC).

  3. Drug

    Poseltinib

    go.drugbank.com/drugs/DB16299
    Investigational

    Poseltinib is under investigation in clinical trial NCT02628028 (A Study of LY3337641 in Rheumatoid Arthritis).

    Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Sodelglitazar

    go.drugbank.com/drugs/DB16332
    Investigational

    Sodelglitazar is under investigation in clinical trial NCT00196989 (Study in People With Type 2 Diabetes).

  5. Drug

    Phorbol 12-myristate 13-acetate diester

    go.drugbank.com/drugs/DB17045
    Investigational

    Phorbol 12-myristate 13-acetate diester is an inducer of neutrophil extracellular traps (NETs).[A253087]

    Synonyms: 12-o-tetradecanoylphorbol-13-acetate
  6. Drug

    Sipagladenant

    go.drugbank.com/drugs/DB17080
    Investigational

    KW-6356 is a selective antagonist of adenosine A2A receptors developed by Kyowa Kirin.[L43822]

  7. Drug

    AAV-CNGB3

    go.drugbank.com/drugs/DB18344
    Investigational

    AAV-CNGB3 is an adenovirus associated viral vector serotype 8 containing the human CNGB3 gene.

  8. Drug

    NXC680

    go.drugbank.com/drugs/DB18366
    Experimental

    NXC680 is a small molecule under investigation for the treatment of idiopathic pulmonary fibrosis (IPF).

  9. Drug

    Zafiride

    go.drugbank.com/drugs/DB18371
    Investigational

    Zafiride is a human tumor necrosis factor coupled to the C terminus of CNGRCG peptide.

  10. Drug

    DNL343

    go.drugbank.com/drugs/DB18678
    Investigational

    DNL343 is under investigation in clinical trial NCT05842941 (HEALEY ALS Platform Trial - Regimen G DNL343).